Neurodegenerative diseases pose a serious threat to public health, with an increasing impact among the elderly population.

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Alphabet is the mother company of Google. Google’s (GOOGL) anti-aging company Calico released disappointing trial results of ...

A research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other neurodegenerative disorders such as ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...

The Vermont Department of Health recently released data from the state's first registry for the disease Amyotrophic Lateral ...

Acetylcysteine zidrimer is under clinical development by Orpheris and currently in Phase II for Amyotrophic Lateral Sclerosis.

It also treats parkinson disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis and other indications where blood brain barrier is impaired. The company operates in Clermont-Ferrand and and ...

A study of human brain organoids suggested a complex relationship between herpes simplex virus 1 infection and tau, ...